Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Laparoscopic cholecystectomy is the treatment of choice for cholecystitis

Better outcomes can be achieved using laparoscopic cholecystectomy compared to open cholecystectomy when treating acute and chronic cholecystitis, finds a new study of 43,433 patients.

News image

fiogf49gjkf04

Laparoscopic cholecystectomy (LC) has become a popular alternative to open cholecystectomy (OC). However, previous studies comparing outcomes in LC and OC have only used small selected cohorts of patients, and did not control for comorbid conditions that might affect outcome.

A report from scientists at the University of North Carolina at Chapel Hill, USA, has now attempted to rectify this.

Writing in the latest issue of the American Journal of Gastroenterology, the research group carried out their study on a large unselected cohort of patients, with the aims of characterizing the morbidity, mortality, and costs of LC and OC.

The group used the population-based North Carolina Discharge Abstract Database for January 1, 1991, to September 30, 1994 (n = 850,000) to identify patients undergoing LC and OC.

This produced a cohort of 43,433 patients (19,662 LC and 23,771 OC).

Indications for surgery, complications, and the type of preoperative biliary imaging used were then identified for all subjects within the cohort.

Open patients - 3 times more likely to die than laparoscopy patients
American Journal of Gastroenterology

In addition, the length of stay, hospital charges, complications, morbidity, and mortality between LC and OC patients were compared.

To account for variations in outcomes from differences in age and comorbidity between the LC and OC groups, researchers applied the age-adjusted Charlson Comorbidity Index in regression analyses quantifying the association between type of surgery and outcome.

The mean-age adjusted Charlson Comorbidity Index score was found to be slightly higher for the OC group compared to the LC group.

The OC patients had longer hospitalizations, generated more charges and also required home care more frequently.

The crude risk ratio, comparing risk of death in OC to LC was 5.0 (95% CI = 3.9-6.5).

After controlling for age, comorbidity, and sex, the likelihood of dying in the OC group was still 3.3 times (95% CI = 1.4-7.3) greater than in the LC group.

In the LC group, the number of patients with acute cholecystitis rose over the study period, whereas the number of patients with chronic cholecystitis declined.

In the OC group however, the number of patients with both chronic and acute cholecystitis declined.

The use of intra-operative cholangiography was greater in the OC group, but declined in both groups over the study period.

The use of ERCP was greater in the LC group and increased in both groups over time.

Summarizing the research group's findings, Dr S.L. Zacks, said, "The introduction of LC has resulted in a change in the management of cholecystitis."

"Despite a higher proportion of patients with acute cholecystitis, our study found the risk of dying was significantly less in LC than in OC patients, even after controlling for age and comorbidity."

He concluded, "Based on lower costs and better outcomes, LC seems to be the treatment of choice for acute and chronic cholecystitis."

Am J Gastroenterol 2002; 97(2): 334-40
12 March 2002

Go to top of page Email this page Email this page to a colleague

 24 November 2017 
Osteoporotic fractures in Barrett's esophagus
 24 November 2017 
Center ERCP volume and procedure success
 24 November 2017 
Adipokines and IBD
 23 November 2017 
Pharmacological management of GERD
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Distance travelling for rectal cancer outcomes
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 21 November 2017 
Prepregnancy obesity and maternal mortality
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Autoimmune pancreatitis in children
 01 November 2017 
Heartburn relief in adolescents with GERD
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us